WESTMINSTER, Colo.--(BUSINESS WIRE)--MDGuidelines®, a leading developer of evidence-based medical treatment guidelines, announced a program to help new health professionals incorporate research into their clinical decision making. This program, branded Starting Line, provides one year of complimentary access to the MDGuidelines solution for medical residents, medical students, and other allied health professional students, such as those in nursing, physical therapy, and occupational health therapy school.
The use of evidence-based medicine has grown dramatically over the past decade. By supporting clinical decisions at the point of care with data from the medical research studies, healthcare organizations can improve outcomes and decrease costs by preventing unnecessary or ineffective medical testing and treatment.
The easy-to-use MDGuidelines web-based solution provides detailed evidence-based information on thousands of conditions and allows medical providers to check diagnoses and treatment plans recommended by the American College of Occupational and Environmental Medicine (ACOEM).
“We want to support medical residents and health students as they develop their practice of medicine so they can be prepared to use evidence-based protocols in the care of their future patients,” said Joe Guerriero, Senior Vice President of MDGuidelines.
Medical residents, medical students, and allied health professional students can sign up for the Starting Line program at www.mdguidelines.com/startingline.
ReedGroup, a wholly owned subsidiary of The Guardian Life Insurance Company of America®, is a leading leave of absence management organization providing outsourcing, software and compliance services to nearly half of the Fortune 100 companies. To learn more follow ReedGroup on Facebook, LinkedIn and Twitter for blogs, webinars, and events.
ReedGroup’s MDGuidelines is the industry’s leading solution for total health management and workplace productivity. MDGuidelines features the world’s most trusted disability duration tables, predictive modeling, analytic services, drug formulary, and evidence-based practice guidelines from ACOEM.